NMPA Drug Approval Roadmap 2025: Ultimate Guide to Regulatory Compliance in China China’s NMPA Drug Approval Guide 2025: Compliance Plan for Pharma Success Introduction to NMPA Regulatory Affairs and Its Importance The National Medical Products Administration (NMPA), formerly known as the CFDA, is China’s regulatory authority responsible for overseeing pharmaceuticals, medical devices, cosmetics, and vaccines. As one of the fastest-growing pharmaceutical markets in the world, China represents a crucial opportunity for multinational companies. However, entering this market requires mastery of NMPA’s rigorous and evolving regulatory frameworks, which emphasize safety, efficacy, and quality while supporting innovation and global integration. For pharmaceutical…